We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

PBT CYCLIC DIMER or Cyclobis(1,4-butylene terephthalate)

Chemical Structure
Specifications
Product name
PBT CYCLIC DIMER or Cyclobis(1,4-butylene terephthalate)
Other Name
3,8,15,20-Tetraoxatricyclo[20.2.2.210,13]octacosa-10,12,22,24,25,27-hexaene-2,9,14,21-tetrone
SRC CAT No
SRC-P16101
CAS No
63440-93-7
Mol.F.
C24H24O8
Mol.Wt.
440.45g/mol
Related CAS No.
NA
Inv Status
In Stock
Chemical Structure
Chemical Structure
view file icon VIEW COA

Chemical Name
3,8,15,20-Tetraoxatricyclo[20.2.2.210,13]octacosa-10,12,22,24,25,27-hexaene-2,9,14,21-tetrone

HSN Code
N.A
Synonym
N.A

Synchemia is a leading Manufacturer in pharmaceutical compounds. PBT CYCLIC DIMER or PBT(Polybutylene Terephthalate) is a general-purpose engineering plastic with excellent electrical properties, mechanical strength, heat resistance, and chemical resistance. It has a fast crystallization rate, making it suitable for injection molding, and is widely used commercially.

 

PBT CYCLIC DIMER  is also known as Cyclobis(1,4-butylene terephthalate) chemically represented as  3,8,12,17-tetraoxa-1,10(1,4)-dibenzenacyclooctadecaphane-2,9,11,18-tetraone. Synchemia is the leading manufacturing and exporter of PBT CYCLIC DImer,we supply PBT CYCLIC DIMER with detailed characterization data compliance with regulatory guidelines.